In the first 2 of a series of 6 new guidelines to be released this year, the American Academy of Dermatology and National Psoriasis Foundation address biologic use and comorbidities in the treatment of psoriasis.

FDA Alerts

FDA Alerts
Saturday, January 16, 2016
The FDA recently approved secukinumab (Cosentyx) for 2 new indications for the treatment of adult patients with active ankylosing spondylitis (AS) and active psoriatic arthritis (PsA).

News

News
Tuesday, April 17, 2018
In a phase 3 trial, researchers investigated the efficacy of a subcutaneous biologic compared with placebo among participants with active psoriatic arthritis. For details from the study, read more.
News
Friday, April 13, 2018
Two phase 3 trials reported on the efficacy and safety of an investigational topical psoriasis treatment in the Journal of the American Academy of Dermatology. For details from the study, read more.
News
Monday, April 2, 2018
Dr Joel Gelfand, professor of dermatology at the University of Pennsylvania Perelman School of Medicine, discusses his latest research on psoriasis and diabetes with Amanda Balbi, managing editor of our sister publication, Consultant360.
News
Friday, March 23, 2018
In a recent study, researchers investigated the long-term efficacy of a psoriasis therapy following withdrawal of treatment among patients with moderate to severe plaque psoriasis.

NPF Endorsed Articles

NPF Endorsed Articles
Tuesday, February 3, 2015
Safe and effective long-term therapy is important when treating patients with psoriasis and maintaining remission of this condition.
NPF Endorsed Articles
Wednesday, January 28, 2015
This article provides several concrete suggestions to help clinicians and patients to enhance their emotional well-being and clinical outcomes.
NPF Endorsed Articles
Monday, December 15, 2014
Test Your Psoriasis Knowledge 1. A 66-year-old woman’s psoriasis suddenly worsened after she underwent a biopsy of a tumor in her breast.
NPF Endorsed Articles
Thursday, October 23, 2014
Thirteen early-career physicians receive National Psoriasis Foundation fellowships to study psoriasis.  

Research in Review

Research in Review
Wednesday, August 10, 2016
A 42-year-old woman with psoriasis presented for evaluation of a new-onset rash of 1 to 2 weeks’ duration on her trunk and extremities.
Research in Review
Monday, July 25, 2016
Getting patients to take medication as prescribed is essential to getting optimal clinical responses.
Research in Review
Thursday, June 16, 2016
Research shows that psoriasis is much more than a skin condition.